Login/Sign Up
Tresivac Vaccine 0.5 ml belongs to the class of medicines called ‘immunizing agents’ used to prevent Measles, Mumps, and Rubella infections. Measles is an infectious viral disease that causes fever and a red rash in children. Mumps is a contagious viral disease caused by a paramyxovirus, which causes fever and swelling, particularly of the parotid gland. Rubella is also a contagious disease caused by the rubella virus. All these conditions can be prevented by effective vaccination.
Tresivac Vaccine 0.5 ml is a vaccine or immunizing agent which is made from a live and weakened or attenuated virus (measles, mumps and rubella). It helps to develop immunity by stimulating the immune system to produce antibodies. It is essential to take the vaccine doses as per the doctor’s advice for effective protection against the disease.
Tresivac Vaccine 0.5 ml will be administered by a healthcare professional. In a few cases, Tresivac Vaccine 0.5 ml may cause side-effects such as low-grade fever, redness, pain, and swelling at the injection site. These side-effects are temporary and resolve over time. However, inform your doctor if any of these side effects persist or get worse.
Before taking Tresivac Vaccine 0.5 ml, inform your doctor if you have any allergy, weak immune system due to long-term diseases such as HIV or cancer, serious infection or illness with fever, blood disorders, immunological diseases, and active untreated tuberculosis. Tresivac Vaccine 0.5 ml should not be used in children under the age of 12 months. Tresivac Vaccine 0.5 ml should not be used in pregnant women. Women of childbearing age should take necessary precautions to avoid pregnancy for at least one month after receiving the vaccine.
Tresivac Vaccine 0.5 ml is used to prevent Measles, Mumps, and Rubella Infections. This vaccine is given as a part of routine vaccination in children. Tresivac Vaccine 0.5 ml can provide immunity within 2 to 6 weeks after taking the injection, which can last life-long. It helps develop immunity by stimulating the immune system to produce antibodies against the virus (Measles, Mumps, and Rubella) that causes Measles, Mumps, and Rubella Infections.
Before taking Tresivac Vaccine 0.5 ml, inform your doctor if you have blood or plasma transfusions or administration of immune globulin (known as IG). In such a case, the doctor may postpone vaccination for at least three months. Immune globulin should not be given for one month after vaccination with Tresivac Vaccine 0.5 ml unless your doctor advises you otherwise. Tresivac Vaccine 0.5 ml should not be given to pregnant women. Women of childbearing potential should use reliable contraception for at least one month after taking Tresivac Vaccine 0.5 ml. Breastfeeding women should take medical advice from the doctor. Keep your doctor informed about your health condition and all the medicines you take before taking Tresivac Vaccine 0.5 ml to rule out any side effects.
Drug-Drug Interactions: Tresivac Vaccine 0.5 ml may interact with medications that help to prevent or reduce the severity of certain infections (e.g. Immune globulin or IG).
Drug-Food Interactions: No interactions found.
Drug-Disease Interactions: Tresivac Vaccine 0.5 ml should not be used in individuals with a weak immune system, blood disorders, infections, immunological diseases, active untreated tuberculosis, and severe illness with fever.
Measles: Measles is an infectious viral disease. A virus in the paramyxovirus family causes it. And it is typically transmitted through direct contact and through the air. Measles symptoms appear one week to two weeks after contact with the virus and typically include high fever, cough, runny nose, and watery eyes.
Mumps: Mumps is a contagious viral disease caused by a paramyxovirus, which causes fever and swelling, particularly of the parotid gland.
Rubella: Rubella is also a contagious disease caused by the rubella virus. Most rubella cases are mild, with symptoms such as a low-grade fever, sore throat, and a rash that begins on the face and spreads to the rest of the body.
About Tresivac Vaccine 0.5 ml
Tresivac Vaccine 0.5 ml belongs to the class of medicines called ‘immunizing agents’ used to prevent Measles, Mumps, and Rubella infections. Measles is an infectious viral disease that causes fever and a red rash in children. Mumps is a contagious viral disease caused by a paramyxovirus, which causes fever and swelling, particularly of the parotid gland. Rubella is also a contagious disease caused by the rubella virus. All these conditions can be prevented by effective vaccination.
Tresivac Vaccine 0.5 ml is a vaccine or immunizing agent which is made from a live and weakened or attenuated virus (measles, mumps and rubella). It helps to develop immunity by stimulating the immune system to produce antibodies. It is essential to take the vaccine doses as per the doctor’s advice for effective protection against the disease.
Tresivac Vaccine 0.5 ml will be administered by a healthcare professional. In a few cases, Tresivac Vaccine 0.5 ml may cause side-effects such as low-grade fever, redness, pain, and swelling at the injection site. These side-effects are temporary and resolve over time. However, inform your doctor if any of these side effects persist or get worse.
Before taking Tresivac Vaccine 0.5 ml, inform your doctor if you have any allergy, weak immune system due to long-term diseases such as HIV or cancer, serious infection or illness with fever, blood disorders, immunological diseases, and active untreated tuberculosis. Tresivac Vaccine 0.5 ml should not be used in children under the age of 12 months. Tresivac Vaccine 0.5 ml should not be used in pregnant women. Women of childbearing age should take necessary precautions to avoid pregnancy for at least one month after receiving the vaccine.
₹594*
MRP ₹660
10% off
₹561*
MRP ₹660
15% CB
₹99 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Online payment accepted
Product Substitutes
Uses of Tresivac Vaccine 0.5 ml
Medicinal Benefits
Tresivac Vaccine 0.5 ml is used to prevent Measles, Mumps, and Rubella Infections. This vaccine is given as a part of routine vaccination in children. Tresivac Vaccine 0.5 ml can provide immunity within 2 to 6 weeks after taking the injection, which can last life-long. It helps develop immunity by stimulating the immune system to produce antibodies against the virus (Measles, Mumps, and Rubella) that causes Measles, Mumps, and Rubella Infections.
Side Effects of Tresivac Vaccine 0.5 ml
Directions for Use
Storage
Drug Warnings
Before taking Tresivac Vaccine 0.5 ml, inform your doctor if you have blood or plasma transfusions or administration of immune globulin (known as IG). In such a case, the doctor may postpone vaccination for at least three months. Immune globulin should not be given for one month after vaccination with Tresivac Vaccine 0.5 ml unless your doctor advises you otherwise. Tresivac Vaccine 0.5 ml should not be given to pregnant women. Women of childbearing potential should use reliable contraception for at least one month after taking Tresivac Vaccine 0.5 ml. Breastfeeding women should take medical advice from the doctor. Keep your doctor informed about your health condition and all the medicines you take before taking Tresivac Vaccine 0.5 ml to rule out any side effects.
Therapeutic Class
Drug-Drug Interactions Checker List
Diet & Lifestyle Advise
Habit Forming
Special Advise
Disease/Condition Glossary
Measles: Measles is an infectious viral disease. A virus in the paramyxovirus family causes it. And it is typically transmitted through direct contact and through the air. Measles symptoms appear one week to two weeks after contact with the virus and typically include high fever, cough, runny nose, and watery eyes.
Mumps: Mumps is a contagious viral disease caused by a paramyxovirus, which causes fever and swelling, particularly of the parotid gland.
Rubella: Rubella is also a contagious disease caused by the rubella virus. Most rubella cases are mild, with symptoms such as a low-grade fever, sore throat, and a rash that begins on the face and spreads to the rest of the body.